RecruitingArthritis Shoulder
Anatomic TSA vs RTSA for Glenohumeral Arthritis
Eligible age
65–85 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
There are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized study is to determine whether RTSA have at least as good results as anatomic TSA (non-inferiority), in patients with glenohumeral osteoarthritis, without rotator cuff tears nor significant glenoid retroversion.
Sponsor: La Tour Hospital
You may qualify if…
- ✓ Primary glenohumeral arthritis,
- ✓ Intact rotator cuff,
- ✓ No important glenoid bone loss (cf exclusion criteria),
- ✓ Patients between 65 and 85 years old
- ✓ Informed Consent as documented by signature (Appendix Informed Consent Form).
You may not qualify if…
- ✕ B2 glenoid with \> 80% posterior humeral head subluxation or greater 25 degrees neoglenoid retroversion,
- ✕ B3 and C type glenoids,
- ✕ Full thickness rotator cuff tear,
- ✕ Acute or malunited proximal humeral fracture,
- ✕ Chronic locked dislocation
- ✕ Rheumatoid arthritis,
- ✕ Revision surgery or surgical antecedents,
- ✕ Tumors,
Source: ClinicalTrials.gov · NCT04629391 · last updated 2026-05-22